anonymous
Guest
anonymous
Guest
I work at BMS, oncology division. Keytruda is kicking our ass in the field because the drug is good and the indications are piling up. Our leadership is clueless and our R&D is worse. We have a terrible team designing our trials and submitting applications to the FDA. I would like to work for Merck but feel like a tool for even considering go to the competition. Why do you folks think?